Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 November 2003, Vol. 102, No. 9, pp. 3129-3135.
Prepublished online as a Blood First Edition Paper on July 3, 2003; DOI 10.1182/blood-2003-04-1300.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-04-1300v1
102/9/3129    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, J.
Right arrow Articles by Karlsson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, J.
Right arrow Articles by Karlsson, S.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Transplantation
Right arrow Cell Cycle
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMATOPOIESIS

TGF-{beta} signaling–deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro

Jonas Larsson, Ulrika Blank, Hildur Helgadottir, Jon Mar Björnsson, Mats Ehinger, Marie-José Goumans, Xiaolong Fan, Per Levéen, and Stefan Karlsson

From the Department of Molecular Medicine and Gene Therapy, Institute of Laboratory Medicine, Lund University Hospital, Lund, Sweden; Department of Pathology, Lund University Hospital, Lund, Sweden; and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Studies in vitro implicate transforming growth factor {beta} (TGF-{beta}) as a key regulator of hematopoiesis with potent inhibitory effects on progenitor and stem cell proliferation. In vivo studies have been hampered by early lethality of knock-out mice for TGF-{beta} isoforms and the receptors. To directly assess the role of TGF-{beta} signaling for hematopoiesis and hematopoietic stem cell (HSC) function in vivo, we generated a conditional knock-out model in which a disruption of the TGF-{beta} type I receptor (T{beta}RI) gene was induced in adult mice. HSCs from induced mice showed increased proliferation recruitment when cultured as single cells under low stimulatory conditions in vitro, consistent with an inhibitory role of TGF-{beta} in HSC proliferation. However, induced T{beta}RI null mice show normal in vivo hematopoiesis with normal numbers and differentiation ability of hematopoietic progenitor cells. Furthermore HSCs from T{beta}RI null mice exhibit a normal cell cycle distribution and do not differ in their ability long term to repopulate primary and secondary recipient mice following bone marrow transplantation. These findings challenge the classical view that TGF-{beta} is an essential negative regulator of hematopoietic stem cells under physiologic conditions in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
S. Karlsson
Is TGF-{beta} a stemness regulator?
Blood, February 5, 2009; 113(6): 1208 - 1208.
[Full Text] [PDF]


Home page
BloodHome page
S. Yamazaki, A. Iwama, S.-i. Takayanagi, K. Eto, H. Ema, and H. Nakauchi
TGF-{beta} as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation
Blood, February 5, 2009; 113(6): 1250 - 1256.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Avagyan, L. Glouchkova, J. Choi, and H.-W. Snoeck
A Quantitative Trait Locus on Chromosome 4 Affects Cycling of Hematopoietic Stem and Progenitor Cells through Regulation of TGF-{beta}2 Responsiveness
J. Immunol., November 1, 2008; 181(9): 5904 - 5911.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Blank, G. Karlsson, and S. Karlsson
Signaling pathways governing stem-cell fate
Blood, January 15, 2008; 111(2): 492 - 503.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. H. Kaplan, M. O. Li, M. C. Jenison, W. D. Shlomchik, R. A. Flavell, and M. J. Shlomchik
Autocrine/paracrine TGF{beta}1 is required for the development of epidermal Langerhans cells
J. Exp. Med., October 29, 2007; 204(11): 2545 - 2552.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Pan, T. Schomber, C. P. Kalberer, L. M. Terracciano, K. Hafen, W. Krenger, H. Hao-Shen, C. Deng, and R. C. Skoda
Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice
Blood, October 15, 2007; 110(8): 3049 - 3055.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Magnusson, A. C. M. Brun, N. Miyake, J. Larsson, M. Ehinger, J. M. Bjornsson, A. Wutz, M. Sigvardsson, and S. Karlsson
HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development
Blood, May 1, 2007; 109(9): 3687 - 3696.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Karlsson, U. Blank, J. L. Moody, M. Ehinger, S. Singbrant, C.-X. Deng, and S. Karlsson
Smad4 is critical for self-renewal of hematopoietic stem cells
J. Exp. Med., March 19, 2007; 204(3): 467 - 474.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Blank, G. Karlsson, J. L. Moody, T. Utsugisawa, M. Magnusson, S. Singbrant, J. Larsson, and S. Karlsson
Smad7 promotes self-renewal of hematopoietic stem cells
Blood, December 15, 2006; 108(13): 4246 - 4254.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Singbrant, J. L. Moody, U. Blank, G. Karlsson, L. Umans, A. Zwijsen, and S. Karlsson
Smad5 is dispensable for adult murine hematopoiesis
Blood, December 1, 2006; 108(12): 3707 - 3712.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. B. Enquist, E. Nilsson, A. Ooka, J.-E. Mansson, K. Olsson, M. Ehinger, R. O. Brady, J. Richter, and S. Karlsson
Effective cell and gene therapy in a murine model of Gaucher disease
PNAS, September 12, 2006; 103(37): 13819 - 13824.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Dong and G. C. Blobe
Role of transforming growth factor-beta in hematologic malignancies
Blood, June 15, 2006; 107(12): 4589 - 4596.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Li and W. B. Neaves
Normal Stem Cells and Cancer Stem Cells: The Niche Matters.
Cancer Res., May 1, 2006; 66(9): 4553 - 4557.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Leveen, M. Carlsen, A. Makowska, S. Oddsson, J. Larsson, M.-J. Goumans, C. M. Cilio, and S. Karlsson
TGF-{beta} type II receptor-deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo
Blood, December 15, 2005; 106(13): 4234 - 4240.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020